𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Antinuclear factor in systemic lupus erythematosus. A consideration of the immunofluorescent method of detecting antinuclear antibodies, with results obtained in a family study

✍ Scribed by John Holborow; Gerald D. Johnson

Publisher
John Wiley and Sons
Year
1964
Tongue
English
Weight
570 KB
Volume
7
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.

✦ Synopsis

An immunofluorescent technique used for demonstrating antinuclear factor is discussed and the possible influence of differences in method on A.N.F. findings in family studies already reported is considered. The incidence of serum antinuclear factor in first degree relatives of patients suffering from systemic lupus erythematosus was higher than in matched population controls; the difference was a small but a significant one.

Es discutite un technica immunofluorescente utilisate pro le demonstration del factor antinuclear. Le possible influentia de differentias in methodo super constatationes de factor antinuclear in previemente reportate studios familial es considerate. In consanguineos del prime grado de patientes suffrente de systemic lupus erythematose le incidentia del factor antinuclear in Ie sero esseva plus grande que in le appariate population de controlo. Iste differentia esseva micre sed significative.

πŸ“œ SIMILAR VOLUMES

Serum complement abnormalities in the an
Serum complement abnormalities in the antinuclear antibody-positive relatives of children with systemic lupus erythematosus
✍ Thomas J. A. Lehman; Virgil Hanson; Bernhard H. Singsen; Helen K. Kornreich; Bra πŸ“‚ Article πŸ“… 1979 πŸ› John Wiley and Sons 🌐 English βš– 458 KB πŸ‘ 2 views

## Abstract Serum C3, C4, and total hemolytic complement (CH50) levels were measured for 21 children with systemic lupus erythematosus (SLE) and 81 first degree relatives. The mean serum C4 and CH50 levels of the 12 relatives with antinuclear antibodies (ANA) were depressed to levels equal to those

The association of antinuclear antibodie
The association of antinuclear antibodies, antilymphocyte antibodies, and c4 activation among the relatives of children with systemic lupus erythematosus. preferential activation of complement in sisters
✍ THOMAS J. A. Lehman; John G. Curd; Nathan J. Zvaifler; Virgil Hanson πŸ“‚ Article πŸ“… 1982 πŸ› John Wiley and Sons 🌐 English βš– 523 KB

## Abstract We studied 31 children with systemic lupus erythematosus (SLE) and 108 first‐degree relatives of the children to determine if HLA type, familial relationship to patient, or gender influenced the familial aggregation of SLE and the serologic and serum complement abnormalities associated

Different manifestations of the antiphos
Different manifestations of the antiphospholipid antibody syndrome in a family with systemic lupus erythematosus
✍ Kimberly P. May; Sterling G. West; Joann Moulds; Brian L. Kotzin πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 524 KB

Familial associations of the antiphospholipid antibody syndrome (APS) offer the opportunity to study genetic mechanisms of autoantibody production and disease, but are unusual. We identified a family, including identical twins and their mother, in which all members had systemic lupus erythematosus (

LJP 394 for the prevention of renal flar
LJP 394 for the prevention of renal flare in patients with systemic lupus erythematosus: Results from a randomized, double-blind, placebo-controlled study
✍ Donato AlarcΓ³n-Segovia; James A. Tumlin; Richard A. Furie; James D. McKay; Mario πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 188 KB πŸ‘ 2 views

## Abstract ## Objective To determine whether LJP 394 delays or prevents renal flare in patients with systemic lupus erythematosus (SLE) and a history of renal disease. ## Methods In a 76‐week, double‐blind, placebo‐controlled study, 230 SLE patients were randomized to receive 16 weekly doses of